Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing
about
Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinPharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next DecadeTesting of VKORC1 and CYP2C9 alleles to guide warfarin dosing. Test category: pharmacogenomic (treatment).Pharmacogenetics in Jewish populations.A review of a priori regression models for warfarin maintenance dose prediction.Pathway analysis of genome-wide data improves warfarin dose prediction.Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.Verification of pharmacogenetics-based warfarin dosing algorithms in Han-Chinese patients undertaking mechanic heart valve replacementCardiovascular pharmacogenomicsCopy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALUPredicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record.Bioinformatics and variability in drug response: a protein structural perspective.Role of pharmacogenomics in the management of traditional and novel oral anticoagulantsPrediction of Warfarin Dose in Pediatric Patients: An Evaluation of the Predictive Performance of Several Models.Current challenges in personalizing warfarin therapy.Prediction of warfarin dose: why, when and how?Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.Warfarin Dosing Algorithms Underpredict Dose Requirements in Patients Requiring ≥7 mg Daily: A Systematic Review and Meta-analysis.Incorporating Pharmacogenomics into Health Information Technology, Electronic Health Record and Decision Support System: An Overview.A systematic analysis and comparison of warfarin initiation strategies.Warfarin genotyping using three different platforms.Verification of five pharmacogenomics-based warfarin administration models.Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients.A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms.The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing.Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort.Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans.Validation of warfarin pharmacogenetic algorithms in clinical practice.Dosage individualization of warfarin using artificial neural networks.Evaluation of CYP2C9- and VKORC1-based pharmacogenetic algorithm for warfarin dose in Gaza-Palestine.Pharmacogenomics Aspect of Warfarin Therapy
P2860
Q28276514-AAE69998-7FB3-4E54-9388-F9B85A84B6CBQ28392069-E42336AD-7BAD-4829-AAB9-5C291E6BFF33Q33704981-9584ED79-2DBD-4519-8000-9B617A6F50A2Q34458720-1FE1065B-3D4A-49F7-A17F-DD39C6728578Q34690708-E453BA22-FC66-45DF-A7BA-9F2BC588BC68Q34790566-55CC15D6-DA34-4D60-95B7-3F1A04C4BFD3Q34791041-990ED111-D310-45BE-B88C-1B3DD28BC414Q35146916-CC426FF8-7293-41E6-BE68-A4ED51785CECQ35447163-3A5B449D-A7B2-4C99-A8DF-315DF84DAA93Q35795982-9252EF99-CC1F-4417-90BB-F360154DDF4EQ35991881-793B812E-41F6-4209-A439-56D2D5DF236EQ36009999-471DC726-97D6-4DEA-9F9B-2D8A3442322FQ36848449-7D768B77-2CBD-48AF-8C65-A7D487249C13Q37115651-42B7126F-475A-4017-9F1D-9CB805AED99DQ37960511-0FD5494E-35A6-4C75-AE74-7DAA84525348Q37989489-69FC196A-C4E3-4462-8C81-47DADBBD5F28Q38897904-FDC7B333-5DF9-4A9A-8AC2-5C45EBE3F6CAQ38979667-D415AECE-3AD6-4703-9811-EED413840364Q39041940-EC497DE1-80D5-4134-9FF9-04E6D6E47655Q40665013-F15AB788-8453-41B3-8D2F-3E35C8CF48EDQ42531773-5590B580-0C70-4EB6-A0DA-A8ECAD77B2B2Q42736252-23775358-DAB1-4EDB-9228-D55FA33639F9Q42750392-E1275800-2BBD-4BAC-89AB-D314711A17E0Q43857194-D06E949A-B7CE-4D35-B64D-ABA7695F26D7Q44498037-5BD8EC4A-4957-489B-9F2F-192B876D5DFCQ46133587-653AC521-4E1D-4F24-BD1B-73EACD1FD427Q46950581-99F8AD90-7A06-45BC-AE7E-B66108544A4DQ50984731-B1D54F22-5782-42B0-8929-81AC02ED7FB6Q51107902-716408CC-1EC9-4182-8842-2501D03C3162Q55379283-AF134C68-E10C-48A6-9FE1-E5FAAB3D4FB6Q57179825-25D58737-8362-4177-AAF2-B5B6A3594A55
P2860
Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Validation and comparison of p ...... ion of pharmacogenetic testing
@ast
Validation and comparison of p ...... ion of pharmacogenetic testing
@en
type
label
Validation and comparison of p ...... ion of pharmacogenetic testing
@ast
Validation and comparison of p ...... ion of pharmacogenetic testing
@en
prefLabel
Validation and comparison of p ...... ion of pharmacogenetic testing
@ast
Validation and comparison of p ...... ion of pharmacogenetic testing
@en
P2093
P2860
P1476
Validation and comparison of p ...... ion of pharmacogenetic testing
@en
P2093
Nitin Roper
Robert Bona
P2860
P304
P356
10.2353/JMOLDX.2010.090110
P577
2010-03-12T00:00:00Z